Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fortyfitt
- Development stage
- Unknown
- Lead developer
- Charak
- Administration
- Oral
01
Overview
Fortyfitt is a proprietary Ayurvedic rejuvenative (Rasayana) formulation developed by Charak Pharma to support overall health, vitality, and stamina in individuals over forty years of age. The tablet formulation contains a synergistic blend of time-tested adaptogenic and antioxidant herbs, including Ashwagandha (*Withania somnifera*), Kapikacchu (*Mucuna pruriens*), Shatavari (*Asparagus racemosus*), and Arjuna (*Terminalia arjuna*). Fortyfitt is indicated for physical, psychological, and sexual debility associated with aging, helping to combat fatigue, reduce oxidative stress, support cognitive function, and promote cardiovascular health.
- Brand names
- Fortyfitt
- Other names
- Fortyfitt TabletFortyfitt Tablets
Beyond the preview
Go deeper on Fortyfitt.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fortyfitt.